Sami Gemayel: We Refuse to Be Held Hostage by Hezbollah

Gemayel speaks during an interview with Asharq Al-Awsat.
Gemayel speaks during an interview with Asharq Al-Awsat.
TT

Sami Gemayel: We Refuse to Be Held Hostage by Hezbollah

Gemayel speaks during an interview with Asharq Al-Awsat.
Gemayel speaks during an interview with Asharq Al-Awsat.

The head of the Lebanese Kataeb Party, Sami Gemayel, warned against some opposition parties resorting to a settlement with Hezbollah in the upcoming presidential elections, noting that the past six years of President Michel Aoun’s reign “led to a complete collapse.”

In an interview with Asharq Al-Awsat, Gemayel said: “We have a basic problem called Hezbollah’s weapon, so let us confront it and stop this procrastination.”

“We are not ready to remain hostages to Hezbollah, and for the state to remain hostage to Hezbollah’s decisions and choices that have nothing to do with Lebanon,” he added.

He also called for placing Hezbollah’s weapons on a “real dialogue table.”

The effort to agree on a single name for the presidency “depends on the ability of the opposition, parties and representatives to surpass personal interests and narrow accounts, and agree on a single strategy to fight this battle,” according to the Lebanese deputy.

“For me, that's the key,” he said. “Names are not important, but the agreement on a unified strategy is… We are supposed to maintain communication with the aim of reaching a strategy…”

Gemayel denied the presence of discrepancies within the opposition about the specifications of the new president.

“We want a president who can be entrusted with the sovereignty of this country; a president who is reformist and capable of action, and who unites all Lebanese,” he underlined.

Gemayel stressed that Hezbollah has been waging an open battle for more than 17 years, to gain control over the country.

He went on to say: “In 2016, [Hezbollah] succeeded in imposing its candidate on the presidency and enforcing a settlement that was accepted by the majority of the political parties, except for us.”

This led to the complete collapse of the country at the economic, social, health and education levels, according to the deputy, who asked: “Will we continue with this approach? Can Lebanon bear that Hezbollah name a new president again for the next six years? Can the Lebanese people tolerate such matters? Is it acceptable for Lebanon to remain isolated from its Arab surroundings and from the international community?”

However, Gemayel underlined the presence of a “real opportunity”, but reiterated that it would require the unity of all opposition blocs.

“Today, we must all have the ability to go beyond our personal considerations to achieve this goal... We [the Kataeb]… believe that our role is to serve Lebanon, not ourselves. For this, we always look to the interest of the country and the cause we are defending,” he told Asharq Al-Awsat.

Nevertheless, Gemayel said he believed that it was still too early to judge the success of this movement, because serious contacts were underway.

He continued: “It is true that [Hezbollah] does not have the majority, and it is also true that the opposition does not have a majority, and therefore we must be humble and communicate together, and put all special considerations aside.”

According to Gemayel, it is still early to talk about a presidential vacuum.

He said in this regard: “We are two months away from the presidential elections. We are still deliberating together on names and discussing each of the possible scenarios to be adopted in our strategy. When we reach the last days of President Aoun’s term, then we will see what the electoral situation and balances will be like… Then we'll talk about this issue.”



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.